Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Hisse Senetlerindeki Sıralama #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Hisse Fiyatı
$44.60
Piyasa Değeri
$108.62B
Değişim (1 gün)
-1.63%
Değişim (1 yıl)
-21.62%
Ülke
FR
Ticaret Sanofi (SNY)

Kategori

Sanofi (SNY) için gelir
Dec 2025 itibarıyla gelir TTM: $54.81B
Sanofi şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $54.81B'dir. 2024 yılında şirketin geliri $46.08B önceki yıla göre artış 2023 yılındaki $46.01B gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Sanofi için 2000 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $54.81B 0.00%
2025 $54.81B 18.94%
2024 $46.08B 0.16%
2023 $46.01B 5.74%
2022 $43.51B -2.33%
2021 $44.55B -2.12%
2020 $45.51B 7.79%
2019 $42.22B 2.98%
2018 $41.00B -5.67%
2017 $43.46B 19.05%
2016 $36.51B -3.56%
2015 $37.85B -2.23%
2014 $38.72B -10.02%
2013 $43.03B -9.28%
2012 $47.43B 4.51%
2011 $45.38B -0.27%
2010 $45.51B 3.21%
2009 $44.09B 9.79%
2008 $40.16B -5.93%
2007 $42.69B 10.03%
2006 $38.80B 15.26%
2005 $33.66B 57.92%
2004 $21.32B 110.71%
2003 $10.12B 29.32%
2002 $7.82B 35.65%
2001 $5.77B 3.32%
2000 $5.58B 0.00%
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
$65.18B 18.92%
US
$58.74B 7.17%
GB
$94.19B 71.85%
US
$61.16B 11.58%
US
$56.15B 2.44%
CH